[1]
A. C. C. Manarelli et al., “INDISCRIMINATE USE OF TIRZEPATIDE (MOUNJARO®): ANALYSIS OF THE MAIN ADVERSE REACTIONS”, REASE, vol. 12, no. 2, pp. 1–20, Feb. 2026, doi: 10.51891/rease.v12i2.24084.